We found that the MAN2B1 expression was an independent prognostic factor for OS and PFS in patients with glioma (high vs. low, HR= 1.33, 95%CI= 1.03-1.70, p =0.028, Figure 4J). This evidence concerns the gene MAN2B1 and central nervous system cancer.